1. HBW Insight
  2. >>Health
  3. >>Business
  4. >>Earnings

Perrigo's Omega Pharma Struggles In 2018 As It Continues To Restructure And Divest

 
• By Tom Gallen

Perrigo's Europe-focused consumer health business Omega Pharma found sales growth hard to come by in 2018 as the group worked hard to right size the organization. While it still has a way to go to completely turnaround Omega, Perrigo is starting to see these interventions pay off, with profits up for the 12 months. 

Nytol Heerbal
Omega Pharma's Nytol Herbal Sleep Aid • Source: Perrigo

Continued efforts by Perrigo Co. PLC to restructure and right-size its Omega Pharma NV consumer health operation hit sales at the Europe-focused business in 2018, with turnover down by 5% for the 12 months.

Perrigo blamed the single-digit slide in Omega’s sales to €988m on the termination of “unprofitable” distribution contracts in Belgium and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

Reducing ‘Complexity Across The Organization’ Tops Kenvue Interim CEO’s Priorities

 
• By Malcolm Spicer

Three weeks into his appointment as interim CEO, Kirk Perry sets priorities including “reduce organizational complexity,” “reinforce a consumer-centric mindset” and “refocus on household penetration.”

Softness In US And China Holds Back Bayer Consumer Health

 
• By Tom Gallen

Like its peers, Bayer Consumer Health has struggled in the challenging US market in the first half of 2025 and says it doesn't expect conditions to change this year.

Repeat Buyers Passing 50% Key For Opill Sales Leading Perrigo’s Women’s Health Growth

 
• By Malcolm Spicer

“We continue to grow the brand. It was slower than initially anticipated or forecasted in basis, but I'm pleased with how it's developing,” says CEO Patrick Lockwood-Taylor of Opill performance.

Recordati Benefits From Cough & Cold Rebound

 
• By Tom Gallen

OTC sales grew at Italy's Recordati in the first half of 2025, with an improving cough and cold picture contributing to the rise.

More from Business

Get To Know: Healthy Aging Specialist Prime Fifty

 
• By David Ridley

Established by Max Gowland in 2013, Prime Fifty was founded to address the specific nutritional needs of the over 50s.

Growing With Purpose – Inside Kenvue’s ‘Healthy Lives Mission’

 
• By David Ridley

HBW Insight speaks to Kenvue's global head of sustainability, Jennifer Duran, about the company's “Healthy Lives Mission,” including insights into how the firm is decarbonizing its supply chain, reducing the use of plastics and embedding sustainability into the design of new products.

Haleon Lowers Sales Guidance On Challenging US Retail Environment

 
• By Tom Gallen

A challenging US retail environment, with consumers cautious around spending, hit Haleon's North America sales in the first half of 2025. With the picture unlikely to improve in the second half, Haleon has lowered its sales guidance for the full year.